Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Shares Up 8 Percent on Strong Growth in Q3 Revenue, Profit

NEW YORK (GenomeWeb News) – Shares in Agilent were up 8.14 percent, or $2.32, at $30.79 in mid-afternoon trading after the company yesterday reported a surge in third-quarter revenue and profit.
 
As GenomeWeb News reported this morning, Agilent said total revenues for the three months ended June 30 increased 17 percent to $1.45 billion from $1.24 billion in the same quarter last year. The company’s net income rose 118 percent to $227 million from $104 million a year ago.
The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.